Cencora Inc. (COR)
Official siteHEALTHCARE • MEDICAL DISTRIBUTION • NYSE
Market Cap: $68.51B
Last updated: Nov 17, 2026 at 11:05 AM ET
Cencora Inc. (COR) Financials: Revenue, Profit and Cash Flow
Cencora reported revenue of $321.33B for the fiscal year ended Sep 30, 2025, up 9.3% from the year before. That year, net income was $1.57B with a net margin of 0.5%, operating cash flow was $3.88B and free cash flow was $3.21B. The quarter ended Jun 30, 2026 had revenue of $84.75B and net income of $776.67M.
Revenue and Margins
The operating margin was 0.8% in the fiscal year ended Sep 2025. Over the 9 years to Sep 2025, revenue grew from $146.85B, a compound annual rate of 9.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Sep 2025 | $321.33B | +9.3% | 3.6% | 0.8% | 0.5% |
| Sep 2024 | $293.96B | +12.1% | 3.4% | 0.7% | 0.5% |
| Sep 2023 | $262.17B | +9.9% | 3.4% | 0.9% | 0.7% |
| Sep 2022 | $238.59B | +11.5% | 3.5% | 1.0% | 0.7% |
| Sep 2021 | $213.99B | +12.7% | 3.2% | 1.1% | 0.7% |
| Sep 2020 | $189.89B | +5.7% | 2.7% | -2.7% | -1.8% |
| Sep 2019 | $179.59B | +6.9% | 2.9% | 0.6% | 0.5% |
| Sep 2018 | $167.94B | +9.7% | 2.7% | 0.9% | 1.0% |
| Sep 2017 | $153.14B | +4.3% | 3.0% | 0.7% | 0.2% |
| Sep 2016 | $146.85B | N/A | 2.9% | 1.0% | 1.0% |
Income Statement
In the fiscal year ended Sep 2025, net income rose 3.3% from the year before. In the quarter ended Jun 2026, net income rose 12.6% from the same quarter a year earlier.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B | $189.89B | $179.59B | $167.94B | $153.14B | $146.85B |
| Cost of revenue | $309.85B | $284.05B | $253.21B | $230.29B | $207.05B | $184.70B | $174.45B | $163.33B | $148.60B | $142.58B |
| Gross profit | $11.48B | $9.91B | $8.96B | $8.30B | $6.94B | $5.19B | $5.14B | $4.61B | $4.55B | $4.27B |
| Operating income | $2.63B | $2.18B | $2.34B | $2.37B | $2.35B | -$5.14B | $1.11B | $1.44B | $1.06B | $1.53B |
| Net income | $1.57B | $1.52B | $1.73B | $1.67B | $1.54B | -$3.40B | $854.13M | $1.62B | $364.48M | $1.43B |
| EBITDA | $3.62B | $3.28B | $3.37B | $3.10B | $2.91B | -$4.73B | $1.62B | $1.93B | $1.50B | $1.92B |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $84.75B | $78.36B | $85.93B | $83.73B | $80.66B | $75.45B | $81.49B | $79.05B | $74.24B | $68.41B | $72.25B | $68.92B |
| Gross profit | $3.61B | $3.59B | $3.07B | $2.95B | $2.91B | $3.06B | $2.56B | $2.49B | $2.41B | $2.54B | $2.47B | $2.25B |
| Operating income | $1.12B | $1.14B | $760.45M | $18.50M | $867.65M | $1.04B | $706.25M | $126.64M | $672.48M | $553.26M | $822.88M | $476.94M |
| Net income | $776.67M | $1.63B | $566.13M | -$333.07M | $689.75M | $717.42M | $493.72M | $7.47M | $487.59M | $421.20M | $603.01M | $348.98M |
Balance Sheet
As of Sep 2025, total debt of $7.66B exceeded cash and equivalents by $3.30B.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $76.59B | $67.10B | $62.56B | $56.56B | $57.34B | $44.27B | $39.17B | $37.67B | $35.32B | $33.64B |
| Current assets | $52.24B | $47.72B | $42.80B | $39.59B | $38.80B | $33.06B | $28.13B | $25.89B | $24.30B | $22.85B |
| Cash and equivalents | $4.36B | $3.13B | $2.59B | $3.39B | $2.55B | $4.60B | $3.37B | $2.49B | $2.44B | $2.74B |
| Total liabilities | $74.84B | $66.31B | $61.89B | $56.49B | $56.75B | $45.11B | $36.18B | $34.62B | $33.25B | $31.51B |
| Short-term debt | $117.78M | $576.33M | $641.34M | $1.07B | $300.21M | $501.26M | $139.01M | $151.66M | $12.12M | $610.21M |
| Long-term debt | $7.54B | $3.81B | $4.15B | $4.63B | $6.38B | $3.62B | $4.03B | $4.16B | $3.43B | $3.58B |
| Shareholder equity | $1.51B | $645.94M | $522.00M | -$211.56M | $223.35M | -$1.02B | $2.88B | $2.93B | $2.06B | $2.13B |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $83.81B | $81.65B | $78.36B | $76.59B | $73.96B | $71.19B | $69.05B | $67.10B | $66.77B | $63.87B | $64.69B | $62.56B |
| Total liabilities | $80.57B | $78.07B | $76.27B | $74.84B | $71.75B | $70.01B | $68.69B | $66.31B | $65.71B | $62.64B | $63.63B | $61.89B |
| Cash and equivalents | $2.82B | $2.18B | $1.75B | $4.39B | $2.23B | $1.98B | $3.22B | $3.23B | $3.31B | $2.07B | $2.87B | $2.69B |
| Shareholder equity | $3.05B | $3.40B | $1.91B | $1.51B | $1.98B | $1.01B | $226.58M | $645.94M | $925.21M | $1.08B | $911.70M | $522.00M |
Cash Flow
In the fiscal year ended Sep 2025, free cash flow was 82.7% of operating cash flow. Dividends and share repurchases together came to 27.2% of it.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.88B | $3.48B | $3.91B | $2.70B | $2.67B | $2.21B | $2.34B | $1.41B | $1.50B | $3.18B |
| Capital expenditures | $667.98M | $487.17M | $458.36M | $496.32M | $438.22M | $369.68M | $310.22M | $336.41M | $466.40M | $464.62M |
| Free cash flow | $3.21B | $3.00B | $3.45B | $2.21B | $2.23B | $1.84B | $2.03B | $1.07B | $1.04B | $2.71B |
| Dividends paid | $437.08M | $416.17M | $398.75M | $391.69M | $366.65M | $343.58M | $338.97M | $333.04M | $320.27M | $288.48M |
| Share repurchases | $435.47M | $1.49B | $1.18B | $483.70M | $82.15M | $420.45M | $674.03M | $639.24M | $329.93M | $2.27B |
| Investing cash flow | -$4.98B | -$618.10M | -$2.60B | -$368.44M | -$6.14B | -$379.87M | -$375.83M | -$1.11B | -$498.04M | -$3.17B |
| Financing cash flow | $2.25B | -$2.33B | -$2.22B | -$1.75B | $1.95B | -$603.62M | -$1.09B | -$242.87M | -$1.31B | $565.07M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.65B | $1.34B | -$2.31B | $3.13B | $109.25M | $3.35B | -$2.72B | $1.00B | $2.48B | -$878.44M | $885.16M | $1.83B |
| Capital expenditures | $226.04M | $165.62M | $119.38M | $249.81M | $183.22M | $129.06M | $105.89M | $182.32M | $117.88M | $112.75M | $74.22M | $175.50M |
| Free cash flow | $2.43B | $1.17B | -$2.42B | $2.88B | -$73.97M | $3.22B | -$2.82B | $818.05M | $2.36B | -$991.20M | $810.94M | $1.65B |
Frequently Asked Questions About COR
What is Cencora's annual revenue?
Cencora reported revenue of $321.33B for the fiscal year ended Sep 30, 2025.
How fast is Cencora's revenue growing?
Revenue was up 9.3% for the fiscal year ended Sep 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 10.4%.
Is Cencora profitable?
Yes. Cencora reported net income of $1.57B for the fiscal year ended Sep 30, 2025, with a net margin of 0.5%.
How much free cash flow does COR generate?
For the fiscal year ended Sep 30, 2025, operating cash flow of $3.88B minus capital expenditures of $667.98M produced free cash flow of $3.21B.
How much debt does Cencora have?
The balance sheet dated Sep 30, 2025 reported long-term debt of $7.54B, short-term debt of $117.78M and cash and equivalents of $4.36B.
COR pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts